Health TrialsbyHealthPanel

Advancing Online Psychology Tools for Chronic Pain

ConditionsFibromyalgiaChronic Pelvic Pain Syndrome
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWomen's College Hospital

About this trial

Chronic pain affects more than 20% of Canadians and is associated with significant impacts on physical function, mental health, and quality of life. Despite efforts to improve access to multidisciplinary pain care through centralized referral systems, many patients continue to experience prolonged wait times before receiving treatment.

This study evaluates a self-guided digital psychological intervention designed to support chronic pain self-management during the waiting period for specialized pain care. The intervention was developed through a collaboration between the Transitional Pain Service and ManagingLife and aims to improve access to evidence-based psychological support, enhance self-management skills, and reduce pain-related distress among individuals living with chronic pain.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Must be deemed to have capacity to provide informed consent;

Must sign and date the informed consent form;

Must state willingness to comply with all study procedures;

Must be at least 18 years of age;

Disqualifiers

Currently engaged in psychotherapy or engaged in psychotherapy within the last month at the time of enrolment;

Unable to read, understand, or communicate in English sufficiently to provide informed consent and complete the study procedures and questionnaires;

Has active serious mental illness or psychiatric instability that, in the opinion of the research team, may impair the ability to safely participate in the study or to provide informed consent (e.g., active psychosis, active mania);

Has a visual, auditory, or other functional impairment that would prevent independent access to and use of the digital intervention and study procedures on an internet-enabled device.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Digital psychology intervention (ADOPT-CP)

    Other intervention

    The intervention, Manage My Pain (MMP), is a clinically validated app-based platform that supports individuals with chronic pain in self-managing their symptoms and improving communication and engagement with their care team.

  • Reminder Emails

    Other intervention

    Weekly emailed pain self-management resources introduced during the Toronto Academic Pain Medicine Institute (TAPMI) orientation

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Intervention GroupExperimental treatment 1 intervention
Group B: Control GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Trial feasibility

Measured according to the CONSORT criteria and include: eligibility rate, recruitment rate, retention rate, measure completion, absence of or minor adverse events.

Time frame
10 weeks
2

Engagement with the digital ADOPT-CP intervention

Measured via MMP app analytics (usage rates, completion of psychology program, etc.)

Time frame
10 weeks
3

Acceptability and Appropriateness of the ADOPT-CP intervention

The Treatment Evaluation Inventory-Short Form (TEI-SF) is a self-report measure assessing the acceptability and perceived appropriateness of a treatment or intervention, with higher scores indicating greater treatment acceptability.

Time frame
10 weeks
4

Acceptability and Adherence of the ADOPT-CP intervention

The Treatment Acceptability/Adherence Scale (TAAS) is a self-report measure assessing perceived acceptability of an intervention and anticipated or actual adherence, with higher scores indicating greater acceptability and adherence.

Time frame
10 weeks

Secondary outcomes

1

Quality of Life and Pain Interference

Modified PROMIS-29 Health Domains (Quality of Life and Pain Interference 8a): A validated patient-reported outcome system assessing the impact of health conditions on physical, mental, and social functioning. Higher scores indicate greater pain interference and worse health-related quality of life, while lower scores indicate better functioning and quality of life.

Time frame
10 weeks
2

Pain Acceptance

Measured by the Chronic Pain Acceptance Questionnaire-Short Form: A validated self-report measure of acceptance of chronic pain. Higher scores indicate greater acceptance of chronic pain, including continued activity engagement and reduced avoidance of pain-related experiences.

Time frame
10 weeks
3

Psychological Flexibility

Measured by the Acceptance and Action Questionnaire-II (AAQ-II): A validated self-report measure of psychological inflexibility and experiential avoidance. Higher scores indicate greater psychological inflexibility and experiential avoidance, while lower scores indicate greater psychological flexibility.

Time frame
10 weeks
4

Kinesiophobia

Measured by the Tampa Scale of Kinesiophobia (TSK): a validated self-report questionnaire used to assess fear of movement and fear of re-injury. Higher scores indicate greater fear of movement.

Time frame
10 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Women's College Hospital

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: